We have previously shown that C2-O-sLeX is a tumor-associated ligand that is abundant on the invasive front of human colon carcinoma tissues, and mediates E-selectin binding when expressed on a colon carcinoma cell line [25], [26]. The gene discussed is SELE; the disease is colon carcinoma.